Abstract：
Antifungal stewardship (AFS), compared with antimicrobial stewardship (AS), requires more advanced knowledge, skills, and multidisciplinary collaboration in its implementation. Therefore, fewer facilities are performing AFS compared with AS. At our hospital, we started AS and AFS in 2014. Our AFS programs include the following: i) interventions for patients with yeast-positive blood cultures, ii) introduction of a conditional antifungal notification system, and iii) commencement of AS team rounds. AFS for filamentous fungi includes bronchoscopy and microbial identification, including genetic and drug susceptibility testing. These AFS activities have improved several processes and outcome measures. However, our AFS team has faced several problems owing to the impact of COVID-19. This review introduces the practice of AFS, which we initiated at our hospital in 2014, and presents the current problems.
摘要：
抗真菌药物管理（AFS），与抗菌药物管理(AS)相比，需要更先进的知识，技能,以及在实施过程中的多学科合作。因此,与AS相比，执行AFS的设施较少。在我们的医院,我们于2014年开始AS和AFS。我们的AFS计划包括以下内容：i)对酵母阳性血培养患者的干预措施，ii)引入有条件的抗真菌通知系统，和iii)AS团队回合的开始。丝状真菌的AFS包括支气管镜检查和微生物鉴定，包括遗传和药物敏感性测试。战地服务团的这些活动改进了若干进程和成果措施。然而,由于COVID-19的影响，我们的AFS团队面临着几个问题。这篇综述介绍了AFS的实践，我们于2014年在我们医院发起，并提出了目前的问题。
